Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. What is graft versus host disease?

    ... In some cases, GVHD can be prevented or treated with immunosuppressive drug therapy . Symptoms should be reported to your doctor immediately. ...

    FAQ last updated 03/15/2016 - 11:26pm.

  2. FAQs

    ... In some cases, GVHD can be prevented or treated with immunosuppressive drug therapy . Symptoms should be reported to your doctor immediately. ...

    Topic section last updated 03/02/2016 - 11:42am.

  3. Pure Red Cell Aplasia (PRCA)

    ... goes away. Transient PRCA is usually triggered by a virus or drug. In most cases, when the virus clears, or the responsible drugs are ... medications are rarely used alone as a treatment. Immunosuppressive therapy may be used if the underlying cause of the PRCA is ...

    Topic section last updated 07/07/2016 - 3:14pm.

  4. Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

    ... Procedure: Bone marrow transplant Day 0 Drug: Thymoglobulin 0.5 mg/kg IV on Day -9 2 mg/kg IV on Days -8, -7 ... congenita or PNH) Failed at least one course of immunosuppressive therapy (if presumed acquired disease). Patients with ...

    Clinical Trial last updated 06/06/2016 - 2:42pm.

  5. Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    ... syndromes (MDS) Associated Drug(s):  Cyclophosphamide ... Active autoimmune disease requiring systemic immunosuppressive therapy Research participants will be excluded, ...

    Clinical Trial last updated 07/14/2016 - 4:08pm.

  6. An Open-label Study of Lirilumab (BMS-986015) in Combination With 5-azacytidine (Vidaza) for the Treatment of Patients With Refractory/ Relapsed Acute Myeloid Leukemia

    ... AML or high-risk MDS. Researchers also want to learn if the drug combination can help to control the disease. The safety of the drug ... and patients with active GVHD will be excluded Ongoing immunosuppressive therapy, including cyclosporine and tacrolimus. ...

    Clinical Trial last updated 06/06/2016 - 1:26pm.

  7. Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

    ... relapsed after, is refractory to induction and/or salvage therapy, or has relapsed after hematopoietic stem cell transplant ... better response. Patient is off or on a stable dose of immunosuppressive drugs for management or prophylaxis of ... Intervention:  Drug: Crenolanib Day 1 of Course 1: once followed by pharmacokinetic ...

    Clinical Trial last updated 06/06/2016 - 10:04am.

  8. FAQs

    ... In some cases, GVHD can be prevented or treated with immunosuppressive drug therapy . Symptoms should be reported to your doctor immediately. ...

    Topic section last updated 03/02/2016 - 11:43am.

  9. SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)

    ... or has a known hypersensitivity to any components of the drug product Patient has an active malignancy and/or cancer history ... examination of cerebrospinal fluid Patient is receiving immunosuppressive therapy, with the exception of corticosteroids as specified ...

    Clinical Trial last updated 06/06/2016 - 2:11pm.

  10. PNH 101: Understanding Diagnosis and Treatment

    ... went over treatment options, including eculizumab , immunosuppressive drug therapy, stem cell transplantation, and supportive therapies like ...

    LMS Item last updated 06/10/2016 - 1:24pm.